Vermillion, Inc. is dedicated to the discovery, development and commercialization of novel high-value diagnostic and bio-analytical solutions that help physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion, along with its prestigious scientific collaborators, discovers, develops, and delivers innovative diagnostic and technology tools that help women with serious diseases. The company’s initial in vitro diagnostic test, OVA1®, was the first FDA-cleared, protein-based In Vitro Diagnostic Multivariate Index Assay, and represented a new class of software-based liquid biopsy in vitro diagnostics. In March 2016 Vermillion received FDA clearance for Overa™, a second generation OVA1 test with significantly improved specificity and ease of use.
View Top Employees from Vermillion, Inc.Website | http://www.vermillion.com |
Ticker | VRML |
Revenue | $3 million |
Funding | $129.3 million |
Employees | 100 (100 on RocketReach) |
Founded | 1993 |
Address | 12117 Bee Caves Rd. Bldg. Three Ste. 100, Austin, Texas 78738, US |
Phone | (512) 519-0400 |
Fax | (512) 439-6980 |
Industry | Test & Measurement Equipment, Diagnostic Equipment, Manufacturing, Laboratory Services (Healthcare), Photographic & Optical Equipment, Consumer Goods |
Competitors | AmberGen, DiagnoCure inc., Genomic Vision, Insight Genetics Inc, Response Genetics |
SIC | SIC Code 38 Companies, SIC Code 382 Companies |
NAICS | NAICS Code 325412 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Vermillion, Inc. employee's phone or email?
The Vermillion, Inc. annual revenue was $3 million in 2023.
Torsten Hombeck is the CFO of Vermillion, Inc..
100 people are employed at Vermillion, Inc..
Vermillion, Inc. is based in Austin, Texas.
The NAICS codes for Vermillion, Inc. are [325412, 3254, 325, 32541, 32].
The SIC codes for Vermillion, Inc. are [38, 382].